Facebook Twitter YouTube  
Contact Us
Search Clinical Trials
Home > Clinical Trials & Research > Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Description   The trial is studying lenalidomide to see how well it works with or without epoetin alfa in treating patients with myelodysplastic syndrome and anemia.

Lenalidomide may stop the growth of myelodysplastic syndrome by blocking blood flow to the cell. Colony stimulating factors, such as epoetin alfa, may increase the number of immune cells found in bone marrow or peripheral blood.

It is not yet known whether lenalidomide is more effective with or without epoetin alfa in treating patients with myelodysplastic syndrome and anemia.
Eligibility Criteria   To be eligible for this study, patients must meet several criteria, including but not limited to the following:

* Patient must be 18 Years and older

* Patient must have Myelodysplastic syndromes (MDS) lasting = 3 months according to WHO criteria.

* Patient must not be pregnant
Principal Investigator   Amit Verma, MD
Contact Name   Dale Wyville, PA
Phone   (718) 405-8547
Contact Email   dwyville@montefiore.org
Post Date   02/12/2009
Protocol Number   2009-257/East
Status   Recruiting
Current Trial Type   Interventional
Montefiore Clinical Trial   No
CHAM Clinical Trial   No